The Federal Trade Commission announced a proposed settlement Thursday with health information technology company Surescripts over a lawsuit accusing the company of using anticompetitive practices to illegally maintain a monopoly over two e-prescription drug markets.
The settlement woud bar Surescripts from engaging in exclusionary conduct and enforcing non-compete agreements with its current and former employees. The FTC said the settlement…